Enhancing Effectiveness Research on Recovery Housing for Persons Prescribed Medication for Opioid Use Disorder

加强阿片类药物使用障碍处方药患者康复住房的有效性研究

基本信息

  • 批准号:
    10590474
  • 负责人:
  • 金额:
    $ 192.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2025-09-29
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Safe and stable housing is widely recognized as critical to recovery from alcohol and drug use disorders generally, but it may be even more critical to recovery from opioid use disorders (OUD). Addiction to opioids is associated with changes in the structure and function of the brain. These changes may take months or years to resolve, all the while leaving individuals vulnerable to relapse, which is all too often deadly. It may also lead to unemployment, criminal justice involvement, and social isolation, which present additional impediments to recovery. Recovery housing can offer invaluable support in the early phases of recovery by providing structure and minimizing exposure to conditioned cues and other triggers for relapse. It can also set the stage for long- term gains by integrating residents into new peer communities that are supportive of recovery and can help as they face challenges in daily life. Unfortunately, research on the outcomes of residents in recovery from OUD, particularly those being treated with medications is limited. Further, there is literature that suggests that individuals being treated with medications for OUD (MOUD) may experience barriers to recovery housing due to negative attitudes towards MOUD and lack of recovery housing that is equipped to support persons on medication. This application seeks to enhance infrastructure to conduct effectiveness research on recovery housing for persons treated with MOUD. Specifically, it aims to: (1) Develop a network of diverse stakeholders dedicated to expanding access to recovery housing for persons prescribed MOUD and conducting research on it; (2) Increase capacity of recovery housing that is equipped to support residents who are prescribed MOUD and to participate in effectiveness research as well as researchers who are trained to conduct it; (3) Provide resources and opportunities to junior investigators and those who may be new to recovery housing research to collaborate with recovery housing researchers to expand the evidence base on recovery housing for persons treated with MOUD. To achieve these aims, the proposed team will establish an Advisory Board comprised of leading researchers and members of national treatment, recovery, and recovery housing organizations to establish a large multi-stakeholder network of providers and researchers. The team will also host a webinar series with intensive year-long tracks for recovery housing providers and researchers new to the field and foster opportunities for these researchers to network with providers and other researchers at conferences. Finally, members of the team will mentor pilot studies with junior and new recovery housing researchers to develop new tools and establish the feasibility of innovative research methods and research in novel settings to fill key gaps in the literature. Findings from these pilot studies will be disseminated to the larger multi-stakeholder network to improve practice and launch wider scale effectiveness research.
项目摘要/摘要 人们普遍认为,安全稳定的住房对于戒除酒精和药物使用障碍至关重要。 一般情况下,但它可能对从阿片使用障碍(OUD)中恢复更为关键。对阿片类药物上瘾 与大脑结构和功能的变化有关。这些变化可能需要几个月或几年的时间才能 决心,同时使个人容易复发,这往往是致命的。它还可能导致 失业、刑事司法介入和社会孤立,这些因素对 恢复。恢复住房可以通过提供结构,在恢复的早期阶段提供宝贵的支持 并最大限度地减少对条件性线索和其他复发诱因的接触。它还可以为长期- 通过让居民融入新的同行社区获得长期收益,这些社区支持复苏,并可以帮助 他们在日常生活中面临着挑战。不幸的是,对住院患者从OUD恢复的结果的研究, 尤其是那些正在接受药物治疗的人是有限的。此外,有文献表明, 正在接受OUD(Moud)药物治疗的个人可能会遇到康复住房的障碍,原因是 对穆德的消极态度和缺乏能够支持人们的恢复住房 药物治疗。此应用程序旨在加强基础设施,以进行恢复有效性研究 为接受穆德治疗的人提供住房。具体地说,它的目标是:(1)发展不同利益攸关方的网络 致力于扩大康复人员获得康复住房的机会,并开展关于 (2)增加恢复住房的容量,以支持按规定提供的居民 以及参与有效性研究以及受过培训的研究人员;(3)提供 为初级调查人员和那些可能是恢复住房研究新手的人提供资源和机会 与康复住房研究人员合作,为人们扩大康复住房的证据基础 接受了穆德的治疗。为实现这些目标,拟议的小组将设立一个咨询委员会,成员包括 主要研究人员和国民待遇、康复和康复住房组织的成员 建立一个由提供者和研究人员组成的大型多方利益相关者网络。该小组还将主持一次网络研讨会 为康复住房提供者和研究人员提供为期一年的密集跟踪系列,这些人员是该领域和福斯特的新手 这些研究人员有机会在会议上与供应商和其他研究人员建立网络联系。最后, 团队成员将指导初级和新的恢复住房研究人员进行试点研究,以开发新的 工具和建立创新研究方法的可行性,并在新的背景下研究,以填补关键空白 在文学作品中。这些试点研究的结果将传播给更大的多方利益攸关方网络,以 改进实践,开展更大范围的成效研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMY Adale MERICLE其他文献

AMY Adale MERICLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMY Adale MERICLE', 18)}}的其他基金

Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based Practices
酒精和药物使用障碍康复住房:一项关于可用性、特征以及与循证实践相关因素的全国研究
  • 批准号:
    9803550
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based Practices
酒精和药物使用障碍康复住房:一项关于可用性、特征以及与循证实践相关因素的全国研究
  • 批准号:
    10016161
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based Practices
酒精和药物使用障碍康复住房:一项关于可用性、特征以及与循证实践相关因素的全国研究
  • 批准号:
    10190748
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
A National Longitudinal Study of the Impact of COVID-19 on Recovery Residences
关于 COVID-19 对康复住宅影响的全国纵向研究
  • 批准号:
    10194298
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based Practices
酒精和药物使用障碍康复住房:一项关于可用性、特征以及与循证实践相关因素的全国研究
  • 批准号:
    10430298
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based Practices
酒精和药物使用障碍康复住房:一项关于可用性、特征以及与循证实践相关因素的全国研究
  • 批准号:
    10445239
  • 财政年份:
    2019
  • 资助金额:
    $ 192.13万
  • 项目类别:
Addiction recovery residences to improve health outcomes in high-risk men
成瘾康复住宅可改善高危男性的健康结果
  • 批准号:
    8846492
  • 财政年份:
    2015
  • 资助金额:
    $ 192.13万
  • 项目类别:
Addiction recovery residences to improve health outcomes in high-risk men
成瘾康复住宅可改善高危男性的健康结果
  • 批准号:
    9050664
  • 财政年份:
    2015
  • 资助金额:
    $ 192.13万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 192.13万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 192.13万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 192.13万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 192.13万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 192.13万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 192.13万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 192.13万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 192.13万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 192.13万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 192.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了